The Curly-Coated Retriever is a historic retrieving breed in the United States, admired for its sharp intelligence, high energy, and warm temperament. They thrive as companions in active households with plenty of exercise and stimulating training routines. However, like many purebred dogs, they are vulnerable to hereditary illnesses such as glycogen storage disease type IIIa (GSDIIIa), a serious genetic disorder impacting glucose metabolism.
Glycogen Storage Disease type IIIa (GSDIIIa) is a genetic disorder specific to Curly-Coated Retrievers caused by a mutation leading to a shortage of the enzyme glucose-6-phosphatase. This enzyme is essential for generating glucose, the body’s main energy source. The deficient enzyme causes glycogen to build up primarily in the liver and muscles, resulting in gradual tissue damage.
Common signs of GSDIIIa include persistent low blood sugar (hypoglycemia), an enlarged liver (hepatomegaly), muscle weakness, seizures, and poor growth. Sadly, without prompt care, puppies afflicted with GSDIIIa may not survive past a young age, as the disease can be fatal early in life.
This disease is inherited following an autosomal recessive pattern. For a dog to express the condition, it must inherit two defective gene copies—one from each parent. Dogs inheriting one copy become carriers, showing no symptoms but capable of passing the gene to their offspring.
Responsible breeding in the US requires knowledge of the genetic status of breeding dogs. Understanding DNA test outcomes assists breeders in making smart pairing decisions to prevent the birth of affected pups.
The most reliable method for determining a Curly-Coated Retriever’s risk for GSDIIIa is DNA testing. Typically, a veterinarian collects either a cheek swab or a blood sample, which is sent to an accredited American veterinary genetics laboratory such as the UC Davis Veterinary Genetics Laboratory or private services like Genomia.
Test results will classify dogs into three categories:
Testing both the sire and dam is crucial to accurately estimate the likelihood of affected offspring.
Breeders in the US should aim to exclusively mate dogs testing clear if possible, and avoid breeding two carriers to prevent puppies affected by GSDIIIa.
Best breeding strategies include:
Sharing DNA test results openly supports overall breed health and helps potential puppy buyers make informed choices.
Early symptoms can be subtle but watch closely for:
If any signs arise, promptly seek evaluation by your US-based veterinarian. Early diagnosis can guide symptom management, improving quality of life, although the overall outlook remains cautious.
Though rare, glycogen storage disease (GSDIIIa) is a serious inherited illness in Curly-Coated Retrievers that requires vigilance and ethical breeding practices. DNA testing provides a key preventive tool to maintain the breed’s wellbeing and avoid puppy suffering.
By following these steps, we can help keep future generations of Curly-Coated Retrievers healthy and joyful members of American families for years to come.